Ainos, Inc. (NASDAQ:AIMD) Sees Significant Growth in Short Interest

Ainos, Inc. (NASDAQ:AIMD) was the target of a large increase in short interest in June. As of June 30th, there was short interest totalling 395,300 shares, an increase of 657.3% from the June 15th total of 52,200 shares. Based on an average daily trading volume, of 657,500 shares, the short-interest ratio is currently 0.6 days. Approximately 13.4% of the shares of the company are sold short.

Ainos Price Performance

Shares of AIMD stock opened at $0.81 on Friday. The stock has a 50 day simple moving average of $0.93 and a 200-day simple moving average of $1.14. Ainos has a 12-month low of $0.77 and a 12-month high of $6.10. The company has a debt-to-equity ratio of 0.10, a current ratio of 0.32 and a quick ratio of 0.28.

Ainos (NASDAQ:AIMD) last issued its earnings results on Monday, May 13th. The company reported ($0.57) earnings per share (EPS) for the quarter. The business had revenue of $0.02 million for the quarter. Ainos had a negative return on equity of 55.38% and a negative net margin of 15,348.14%.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.